Validation of Interferon Regulatory Factor 1 and Nicotinamide Phosphoribosyltransferase as Prognostic Biomarkers and Potential Therapeutic Targets in Clear Cell Renal Cell Carcinoma
Xiaomeng Zhang, Xin Yang, Yan Zhang, Ye Fan, Yingying Zhu
Elsevier ·
2026-09-01
· DOI 10.1016/j.cmp.2026.09.009
The publisher did not provide an abstract — full text is available via the link below.
Xiaomeng Zhang, Xin Yang, Yan Zhang, Ye Fan, Yingying Zhu. Validation of Interferon Regulatory Factor 1 and Nicotinamide Phosphoribosyltransferase as Prognostic Biomarkers and Potential Therapeutic Targets in Clear Cell Renal Cell Carcinoma. // Current Molecular Pharmacology. – 2026. – DOI: 10.1016/j.cmp.2026.09.009. – URL: https://doi.org/10.1016/j.cmp.2026.09.009
Xiaomeng Zhang, Xin Yang, Yan Zhang, Ye Fan, & Yingying Zhu (2026). Validation of Interferon Regulatory Factor 1 and Nicotinamide Phosphoribosyltransferase as Prognostic Biomarkers and Potential Therapeutic Targets in Clear Cell Renal Cell Carcinoma. Current Molecular Pharmacology. https://doi.org/10.1016/j.cmp.2026.09.009
Xiaomeng Zhang, et al. “Validation of Interferon Regulatory Factor 1 and Nicotinamide Phosphoribosyltransferase as Prognostic Biomarkers and Potential Therapeutic Targets in Clear Cell Renal Cell Carcinoma.” Current Molecular Pharmacology, 2026. doi:10.1016/j.cmp.2026.09.009.
@article{Zhang2026,
title = {Validation of Interferon Regulatory Factor 1 and Nicotinamide Phosphoribosyltransferase as Prognostic Biomarkers and Potential Therapeutic Targets in Clear Cell Renal Cell Carcinoma},
author = {Zhang, Xiaomeng and Yang, Xin and Zhang, Yan and Fan, Ye and Zhu, Yingying},
journal = {Current Molecular Pharmacology},
year = {2026},
doi = {10.1016/j.cmp.2026.09.009},
url = {https://doi.org/10.1016/j.cmp.2026.09.009}
}